Downregulation of Crystallin Lambda 1 is a New Independent Prognostic Marker in Clear Cell Renal Cell Carcinoma

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Linehan WM, Ricketts CJ. The cancer genome atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019;16(9):539–552. doi:10.1038/s41585-019-0211-5
   PubMed Web of Science ®Google Scholar
• Singh D. Current updates and future perspectives on the management of renal cell carcinoma. Life Sci. 2021;264:118632.
   PubMed Web of Science ®Google Scholar
• Wistow G. The human crystallin gene families. Hum Genomics. 2012;6(1):26.
   PubMedGoogle Scholar
• Malin D, Petrovic V, Strekalova E, Sharma B, Cryns VL. αB-crystallin: portrait of a malignant chaperone as a cancer therapeutic target. Pharmacol Ther. 2016;160:1–10.
   PubMed Web of Science ®Google Scholar
• Hallen A, Cooper AJ, Jamie JF, Haynes PA, Willows RD. Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones. J Neurochem. 2011;118(3):379–387.
   PubMed Web of Science ®Google Scholar
• Aksoy O, Pencik J, Hartenbach M, et al. Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer. Int J Cancer. 2021;148(3):731–747.
   PubMed Web of Science ®Google Scholar
• Gusareva ES, Carrasquillo MM, Bellenguez C, et al. Genome-wide association interaction analysis for Alzheimer’s disease. Neurobiol Aging. 2014;35(11):2436–2443.
   PubMed Web of Science ®Google Scholar
• Tindale LC, Leach S, Spinelli JJ, Brooks-Wilson AR. Lipid and Alzheimer’s disease genes associated with healthy aging and longevity in healthy oldest-old. Oncotarget. 2017;8(13):20612–20621.
   PubMedGoogle Scholar
• Chen J, Yu L, Li D, et al. Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians. Gene. 2003;302(1–2):103–113. doi:10.1016/S0378-1119(02)01095-8
   PubMed Web of Science ®Google Scholar
• Cheng IK, Ching AK, Chan TC, et al. Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis. J Pathol. 2010;220(3):348–360. doi:10.1002/path.2644
   PubMed Web of Science ®Google Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678. doi:10.1038/s41587-020-0546-8
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110. doi:10.1158/0008-5472.CAN-17-0307
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–W560. doi:10.1093/nar/gkz430
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. doi:10.1038/ncomms3612
   PubMed Web of Science ®Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200–4202. doi:10.1093/bioinformatics/btz210
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Lulli M, Nencioni D, Papucci L, Schiavone N. Zeta-crystallin: a moonlighting player in cancer. CMLS. 2020;77(6):965–976. doi:10.1007/s00018-019-03301-3
   PubMed Web of Science ®Google Scholar
• Mulders JW, Hendriks W, Blankesteijn WM, Bloemendal H, de Jong WW. Lambda-crystallin, a major rabbit lens protein, is related to hydroxyacyl-coenzyme A dehydrogenases. J Biol Chem. 1988;263(30):15462–15466. doi:10.1016/S0021-9258(19)37611-2
   PubMed Web of Science ®Google Scholar
• Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–161. doi:10.1016/j.cmet.2013.05.017
   PubMed Web of Science ®Google Scholar
• Sanchez DJ, Simon MC. Genetic and metabolic hallmarks of clear cell renal cell carcinoma. Biochim Biophys Acta Rev Cancer. 2018;1870(1):23–31. doi:10.1016/j.bbcan.2018.06.003
   PubMed Web of Science ®Google Scholar
• He YY, Liu SB, Lee WH, Zhang Y. Melanoma cell growth inhibition by betagamma-CAT, which is a novel non-lens betagamma-crystallin and trefoil factor complex from frog Bombina maxima skin. Toxicon. 2008;52(2):341–347. doi:10.1016/j.toxicon.2008.06.002
   PubMed Web of Science ®Google Scholar
• Aggarwal V, Montoya CA, Donnenberg VS, Sant S. Interplay between tumor microenvironment and partial EMT as the driver of tumor progression. iScience. 2021;24(2):102113. doi:10.1016/j.isci.2021.102113
   PubMed Web of Science ®Google Scholar
• Guo S, Deng CX. Effect of stromal cells in tumor microenvironment on metastasis initiation. Int J Biol Sci. 2018;14(14):2083–2093. doi:10.7150/ijbs.25720
   PubMed Web of Science ®Google Scholar
• Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61–68. doi:10.1016/j.canlet.2016.01.043
   PubMed Web of Science ®Google Scholar
• Kwapisz O, Górka J, Korlatowicz A, et al. Fatty acids and a high-fat diet induce epithelial-mesenchymal transition by activating TGFβ and β-catenin in liver cells. Int J Mol Sci. 2021;22:3.
   Google Scholar
• Li M, Bu X, Cai B, et al. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review). Oncol Rep. 2019;41(2):727–741.
   PubMed Web of Science ®Google Scholar
• Piva F, Giulietti M, Santoni M, et al. Epithelial to mesenchymal transition in renal cell carcinoma: implications for cancer therapy. Mol Diagn Ther. 2016;20(2):111–117.
   PubMed Web of Science ®Google Scholar